title: If heparanase is the answer, what is the question?
authors.affiliation: Department of Medicine, The George Washington University, Washington, DC, USA. frickles@faseb.org
authors.forename: F R
authors.initials: FR
authors.lastname: Rickles
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D005966:Glucuronidase / Q000378:metabolism*; D006493:Heparin / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy / Q000201:enzymology*; D000099175:Heparanase
chemical_list: D000925:Anticoagulants; D004791:Enzyme Inhibitors; D005966:Glucuronidase; D006493:Heparin; D006495:Heparin, Low-Molecular-Weight; D000099175:Heparanase